Link Pharma Chem has informed that pursuant to the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, a meeting of the Board of Directors of the Company is scheduled to be held on Friday, 07th February, 2025, to consider and approve the unaudited financial results of the Company for the quarter and nine months ended on December 31, 2024. Further, in terms of the SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company’s Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons, the trading window of the Company is already closed from 01st January, 2025 and will open 48 hours after the declaration of unaudited financial results for the quarter and nine months ended on December 31, 2024, intimation of which has already been provided to BSE as on December, 25, 2024.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1735.45 |
Dr. Reddys Lab | 1144.05 |
Cipla | 1441.70 |
Lupin | 2026.50 |
Zydus Lifesciences | 885.70 |
View more.. |